Publiziert in: Marktpuls, Unternehmen, Neuemissionen
Frei

CREDIT SUISSE NEW ISSUE: 9 American Call Warrants on Vifor Pharma Mittwoch, 14. April 2021 - 15:14

Dear Investor

Please find hereafter the details for these new issues:

Ticker

Valor

ISIN

Underlying

Spot

Strike

Ratio

Maturity

Type

Issue price

Impl. Vola

PDF File

VIFACS 

11 104 2356 

CH 111 042 356 8 

Vifor Pharma AG 

CHF 130.00 

CHF 140.00 

50:1 

17.12.2021 

Call 

CHF 0.15 

28.21% 

VIFACS_111042356_CW_TSi.pdf

VIFBCS 

11 104 2357 

CH 111 042 357 6 

Vifor Pharma AG 

CHF 130.00 

CHF 145.00 

50:1 

17.12.2021 

Call 

CHF 0.11 

27.27% 

VIFBCS_111042357_CW_TSi.pdf

VIFCCS 

11 104 2358 

CH 111 042 358 4 

Vifor Pharma AG 

CHF 130.00 

CHF 150.00 

50:1 

17.12.2021 

Call 

CHF 0.09 

26.95% 

VIFCCS_111042358_CW_TSi.pdf

VIFDCS 

11 104 2359 

CH 111 042 359 2 

Vifor Pharma AG 

CHF 130.00 

CHF 145.00 

50:1 

17.06.2022 

Call 

CHF 0.19 

29.09% 

VIFDCS_111042359_CW_TSi.pdf

VIFECS 

11 104 2360 

CH 111 042 360 0 

Vifor Pharma AG 

CHF 130.00 

CHF 150.00 

50:1 

17.06.2022 

Call 

CHF 0.16 

28.38% 

VIFECS_111042360_CW_TSi.pdf

VIFFCS 

11 104 2361 

CH 111 042 361 8 

Vifor Pharma AG 

CHF 130.00 

CHF 155.00 

50:1 

17.06.2022 

Call 

CHF 0.13 

27.86% 

VIFFCS_111042361_CW_TSi.pdf

VIFGCS 

11 104 2362 

CH 111 042 362 6 

Vifor Pharma AG 

CHF 130.00 

CHF 150.00 

50:1 

16.12.2022 

Call 

CHF 0.22 

29.20% 

VIFGCS_111042362_CW_TSi.pdf

VIFHCS 

11 104 2363 

CH 111 042 363 4 

Vifor Pharma AG 

CHF 130.00 

CHF 155.00 

50:1 

16.12.2022 

Call 

CHF 0.19 

28.58% 

VIFHCS_111042363_CW_TSi.pdf

VIFICS 

11 104 2364 

CH 111 042 364 2 

Vifor Pharma AG 

CHF 130.00 

CHF 160.00 

50:1 

16.12.2022 

Call 

CHF 0.16 

28.25% 

VIFICS_111042364_CW_TSi.pdf


Please visit our website http://www.credit-suisse.com/derivatives to see the complete list of our products.

The warrants will be placed directly in the secondary market. Please call 044/335 76 00.

Kind regards

CREDIT SUISSE AG
Investment Banking
Equity Derivatives & Structured Products
Uetlibergstrasse 231
8070 Zürich, Switzerland
Tel: +41 44 - 335 76 00
Fax: +41 44 - 333 78 08

www.credit-suisse.com

This message may contain confidential, proprietary or legally privileged information and is intended only for the use of the addressee named above. No confidentiality or privilege is waived or lost by any mistransmission. If you are not the intended recipient of this message you are hereby notified that you must not use, disseminate, copy it in any form or take any action in reliance on it. If you have received this message in error please delete it and any copies of it and notify the sender immediately. Credit Suisse Group and its subsidiaries reserve the right to intercept and monitor any e-mail communication through its networks if legally allowed.